L01BB02 · Antineoplastic and immunomodulating agents
Xaluprine (previously Mercaptopurine Nova Laboratories)
Indications
Xaluprine is indicated for the treatment of acute lymphoblastic leukaemia (ALL) in adults, adolescents and children.
Composition
- Active substance
- 6-mercaptopurine monohydrate
- International name (INN)
- mercaptopurine
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Xaluprine (previously Mercaptopurine Nova Laboratories)
- Active substance
- 6-mercaptopurine monohydrate
- ATC code
- L01BB02
- Therapeutic area
- Leukemia, Lymphoid
- Marketing authorisation holder
- Lipomed GmbH